Protocol for assessing the impact of the 6th National Audit Project recommendations on practice

Sigrún Eyrúnardóttir Clark, Iain Moppett, S. Ramani Moonesinghe, Cecilia Vindrola-Padros
{"title":"Protocol for assessing the impact of the 6th National Audit Project recommendations on practice","authors":"Sigrún Eyrúnardóttir Clark, Iain Moppett, S. Ramani Moonesinghe, Cecilia Vindrola-Padros","doi":"10.1101/2024.05.03.24306350","DOIUrl":null,"url":null,"abstract":"Patient safety has been a growing area of concern, especially within perioperative care where risks of major complications during surgery exist. Anaphylaxis in the operating theatre is a life-threatening drug reaction that happens suddenly, without warning and can affect anyone. The 6th National Audit Project (NAP6) of the Royal College of Anaesthetists (RCoA): Perioperative Anaphylaxis was the largest ever prospective study of anaphylaxis related to anaesthesia and surgery. The findings from the audit were collated into a report and included recommendations for improved patient care. The purpose of this study is to understand the perceptions of the NAP6 recommendations and their impact on practice. This study will use ethnographic qualitative methods in the form of observations, interviews and a documentary analysis. The sessions targeted for observations will include departmental or hospital meetings, and educational or training sessions, related to perioperative anaphylaxis. The target sample size of 78 healthcare professionals across six hospitals within England, will include individuals with roles specific to anaesthesia, surgery, immunology, allergy and governance. Additionally, six stakeholders will be interviewed who can provide insights into the NAP6 recommendations at the national level. Across the six sites, local collaborators will share any relevant documents related to perioperative anaphylaxis or the NAP-6 recommendations. The study has received regulatory approvals from the Health Research Authority and has been funded by the National Institute for Health and Care Research.","PeriodicalId":501051,"journal":{"name":"medRxiv - Surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv - Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2024.05.03.24306350","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Patient safety has been a growing area of concern, especially within perioperative care where risks of major complications during surgery exist. Anaphylaxis in the operating theatre is a life-threatening drug reaction that happens suddenly, without warning and can affect anyone. The 6th National Audit Project (NAP6) of the Royal College of Anaesthetists (RCoA): Perioperative Anaphylaxis was the largest ever prospective study of anaphylaxis related to anaesthesia and surgery. The findings from the audit were collated into a report and included recommendations for improved patient care. The purpose of this study is to understand the perceptions of the NAP6 recommendations and their impact on practice. This study will use ethnographic qualitative methods in the form of observations, interviews and a documentary analysis. The sessions targeted for observations will include departmental or hospital meetings, and educational or training sessions, related to perioperative anaphylaxis. The target sample size of 78 healthcare professionals across six hospitals within England, will include individuals with roles specific to anaesthesia, surgery, immunology, allergy and governance. Additionally, six stakeholders will be interviewed who can provide insights into the NAP6 recommendations at the national level. Across the six sites, local collaborators will share any relevant documents related to perioperative anaphylaxis or the NAP-6 recommendations. The study has received regulatory approvals from the Health Research Authority and has been funded by the National Institute for Health and Care Research.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
第六次国家审计项目建议对实践影响的评估规程
患者安全一直是人们日益关注的问题,尤其是在围手术期护理中,因为手术期间存在发生重大并发症的风险。手术室中的过敏性休克是一种危及生命的药物反应,会在毫无征兆的情况下突然发生,任何人都可能受到影响。英国皇家麻醉师学院 (RCoA) 的第六次全国审计项目 (NAP6):围术期过敏性休克是有史以来规模最大的与麻醉和手术相关的过敏性休克前瞻性研究。审计结果被整理成一份报告,其中包括改善患者护理的建议。本研究旨在了解人们对 NAP6 建议的看法及其对实践的影响。本研究将采用观察、访谈和文献分析等人种学定性方法。观察对象包括与围手术期过敏性休克相关的部门或医院会议、教育或培训课程。目标样本量为英格兰六家医院的 78 名医护人员,其中包括麻醉、手术、免疫学、过敏和管理方面的专业人员。此外,还将对六名利益相关者进行访谈,他们可以为国家层面的 NAP6 建议提供见解。在这六个地点,当地合作者将共享与围术期过敏性休克或 NAP-6 建议相关的任何文件。该研究已获得卫生研究局的监管批准,并得到了国家卫生与护理研究所的资助。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The VIPR-1 trial (Visualizing Ischemia in the Pancreatic Remnant) - Assessing the role of intraoperative indocyanine green perfusion of the transected pancreas in predicting postoperative pancreatic leaks: protocol for a prospective phase II trial. Insulin-dependence as a Predictor of Shortened Cancer-specific Survival in Pancreatic Neuroendocrine Tumors: A Multi-Institutional Study from the United States Neuroendocrine Study Group Chyme Reinfusion Practices in the Neonatal Population Traumatic Amputations - A Nationwide Epidemiological Analysis of a developing country over 16 years Development and Validation of Collaborative Robot-assisted Cutting Method for Iliac Crest Flap Raising: Randomized Crossover Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1